NPT Texxon Holding Ltd Annual reports only
Wholesale-Chemicals & Allied Products · Nasdaq · SEC CIK 2014337 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-39.3%
TTM net income YoY-420.6%
TTM EPS YoY-360.0%
Revenue 3-yr CAGR-4.3%
Net income 3-yr CAGR—
Margins
Gross margin0.2%
Operating margin-1.7%
Net margin-1.0%
FCF margin-2.7%
EBITDA margin-1.3%
Returns
ROE-176.4%
ROA-3.2%
ROIC (approx.)-16.6%
Asset turnover3.18x
Leverage & solvency
Liabilities / assets65.1%
Debt / equity4.51x
Current ratio0.45x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.36x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $484.04M | $797.15M |
| Cost of revenue | $482.94M | $792.45M |
| Gross profit | $1.10M | $4.70M |
| SG&A expense | $7.35M | $2.89M |
| Operating income | -$8.08M | -$600,646 |
| Pretax income | -$8.99M | -$737,235 |
| Income tax | $0 | $716,897 |
| Net income | -$4.86M | -$932,621 |
| EBITDA | -$6.45M | -$312,574 |
| EPS (basic) | -0.23 | -0.05 |
| EPS (diluted) | -0.23 | -0.05 |
| Weighted avg. shares (diluted) | 21.50M | 20.00M |
| Balance sheet | ||
| Cash & equivalents | $94,101 | $2.52M |
| Receivables | $1.10M | $7.52M |
| Inventory | $2.01M | $973,644 |
| Current assets | $35.06M | $20.76M |
| PP&E, net | $121.11M | $84.62M |
| Intangibles | $6.79M | $6.16M |
| Total assets | $165.24M | $138.97M |
| Current liabilities | $77.79M | $72.74M |
| Short-term debt | $12.26M | $0 |
| Long-term debt | $29.75M | $32.18M |
| Total debt | $42.02M | $32.18M |
| Total liabilities | $107.60M | $104.92M |
| Shareholders' equity | $9.32M | -$3.81M |
| Net debt | $41.92M | $29.66M |
| Shares outstanding | 22.18M | 20.00M |
| Cash flow statement | ||
| Operating cash flow | $1.76M | $2.32M |
| Capital expenditure | $14.77M | $45.10M |
| Free cash flow | -$13.01M | -$42.78M |
| Investing cash flow | -$15.03M | -$42.25M |
| Financing cash flow | $10.39M | $41.36M |
| Depreciation & amortization | $1.63M | $288,072 |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.